Antimicrobial Resistance profile of Staphylococcus aureus from dairy cows with mastitis in the Region of Central Macedonia over a five-month period (March-July 2021)


Published: Jul 11, 2024
Versions:
2024-07-11 (1)
Keywords:
Antimicrobial Resistance Staphylococcus aureus mastitis prudent use of antibiotics One Health
C Zafeiridis
E Pavlidou
P Giakkoup
A Vatopoulos
E Papadogiannakis
Abstract

In Greece, a National Monitoring Plan for Antimicrobial Resistance in sick bovine animals was launched (2021). We aimed at surveying the antimicrobial resistance profiles of 118 pathogenic Staphylococcus aureus isolates obtained from dairy cows >18 months with mastitis in the Region of Central Macedonia from 1st March to 31st July 2021, where 45% (Census 2020: 69.186/128.511) of dairy cows in Greece are concentrated. By using the disk diffusion method (according to the CLSI guidelines), we tested susceptibility of isolates to nine antimicrobials (penicillin, cefoxitin, cefquinome, gentamicin, tetracycline, marbofloxacin, erythromycin, clindamycin, enrofloxacin) selected following the marketing amounts of animal use in Greece. In the study, 62/11 Staphylococcus aureus isolates were found to be resistant 52,54% to penicillin; 57/118 were 48,31% resistant to erythromycin, 56/118 were resistant 47,46% to clindamycin; 29/118 were 24,58% resistant to tetracycline and cefquinome both, 27/118 were 22,88% resistant to cefoxitin, 20/118 were 16,95% resistant to gentamicin, 3/118 were 2,54% resistant to marbofloxacin and, 2/118 were 1,69% resistant to enrofloxacin. Regarding the surveillance on the antimicrobial resistance of the Staphylococcus aureus isolates, that cause mastitis in cattle (penicillin in combination with an aminoglycoside, is the most commonly applied therapeutic treatment scheme against mastitis in Greece), to the β-lactams (penicillin, cefoxitin) it is needed further investigation, under the ‘One Health’ approach in respect to the prudent use of antibiotics in staphylococcal infections in humans and in the veterinary medicine in Greece. However, it seems that several kinds of interventions at farm level led to the protection of quinolones. The study offers a thorough understanding of the antimicrobial resistance patterns among Staphylococcus aureus isolates. The significant resistance rates to various antibiotics highlight the need for responsible antibiotic usage and continuous monitoring of resistance trends. These insights are crucial in developing effective strategies to tackle the emergence and dissemination of resistant strains and ensuring better treatment and control of infections caused by this bacterium. The findings add valuable knowledge to our understanding of antibiotic resistance and its implications.


Keywords: Antimicrobial Resistance; Staphylococcus aureus; mastitis; prudent use of antibiotics; One Health

Article Details
  • Section
  • Research Articles
Downloads
Download data is not yet available.
References
Assessing the Health burden of infections with antibiotic-resistant bacteria in the European Union (EU) or European Economic Area, 2016-
- Technical Report (2022). The European Centre for Disease
Prevention and Control (ECDC). (Stockholm) Sweden, pp 13-14.
A European One Health Action Plan Against Antimicrobial Resistance
(2017). European Commission (Brussels) Belgium, pp 3-4.
The Antimicrobial Resistance in the European Union (EU) or European
Economic Area (EEA) - European Antimicrobial Resistance Surveillance Network (EARS-Net) - Annual Epidemiological Report for
(2020). The European Centre for Disease Prevention and Control (ECDC). (Stockholm) Sweden, pp 6-7.
Mader, R., Zafeiridis, C. et al. (2022) Review and Analysis of National
Monitoring Systems for Antimicrobial Resistance in Animal Bacterial Pathogens in Europe: A Basis for the Development of the European
Antimicrobial Resistance Surveillance Network in Veterinary Medicine (EARS-Vet), Frontiers in Microbiology, 13: pp 8-10
Mader, R., Zafeiridis, C. et al. (2022) Defining the Scope of the European
Antimicrobial Resistance Surveillance Network in Veterinary Medicine (EARS-Vet): A Bottom-up and One Health Approach. Journal of
Antimicrobial Chemotherapy, 77: pp 818-820
Reflection paper on off-label use of antimicrobials in veterinary medicine in the European Union - European Medicines Authority (EMA)
- Committee for Medicinal Products for Veterinary Use (CVMP)
(2018). (London) United Kingdom, p16-19
Kotzamanidis, C. et al. (2021) Staphylococcus aureus Isolated from
Ruminants with Mastitis in Northern Greece Dairy Herds: Genetic
Relatedness and Phenotypic and Genotypic Characterization, MDPI
- Toxins, 13: pp 8-11
Rana et al. (2022) Frequently used therapeutic antimicrobials and their
resistance patterns on Staphylococcus aureus and Escherichia coli in
mastitis affected lactating cows. International Journal of Veterinary
Science and Medicine, 10: pp 5-8
Visciano P. et al. (2014) Detection of methicillin-resistant Staphylococcus
aureus in dairy cow farms. Food Control, 46: pp 534-536
Schlotter K. et al. (2014) Multiple cases of methicillin-resistant CC130
Staphylococcus aureus harboring mecC in milk and swab samples
from a Bavarian dairy herd. 2784-2785. Journal of Dairy Science,
: pp 2784-2785
Kuhnen S. et al. (2021) Identification and antimicrobial susceptibility of
milk pathogen isolated from dairy production systems. Preventive
Veterinary Medicine, 194: pp 2-3
El Garch et al. (2020) Antimicrobial susceptibility of nine udder pathogens recovered from bovine clinical mastitis milk in Europe 2015-
: VetPath results. Veterinary Microbiology: 245, pp 2-9
C. Zafeiridis et al. (2023) Building the National Antimicrobial Resistance
Surveillance Network in Animals in Greece: A “One Health” Approach. Antibiotics, 12 (9): pp 1-13
Most read articles by the same author(s)